Alpha Tau Medical EBIT

Alpha Tau Medical (DRTS) currently reports a EBIT of $-50M as of June 2026. That compares with $-32M in the prior-year period — down 55.4% year over year. That is below the sector sector average of $-6.4M. Use the charts on this page to explore Alpha Tau Medical's EBIT history and peer comparisons.

Alpha Tau Medical's EBIT decreased from $-32M to $-50M — a 55.4% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Alpha Tau Medical's EBIT of $-50M is lower than the its sector sector average of $-6.4M. That is roughly 687.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Alpha Tau Medical reported $-50M in EBIT as of June 2026. That compares with $-32M in the prior-year period — down 55.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-50M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $-6.4M. From there, open related valuation or income-statement pages for Alpha Tau Medical, and consider following DRTS for alerts when major investors trade the stock.